Menu
Menu
OsteoSee is developing the world’s first 360° solution to
accurately manage bone health care, anytime, anywhere.
Osteoporosis:
A silent, deadly disease
that is rarely assessed
200 MILLION
PEOPLE
WORLDWIDE
are affected by
Osteoporosis
20%
DIE
from osteoporotic
hip fracture in
first year
40%
unable
to walk
independently after
hip fracture
Hospital
admission
More days in
hospital than
other diseases
Costs $17
Billion
in the U.S.
alone
200 MILLION
PEOPLE
WORLDWIDE
are affected by
Osteoporosis
20%
DIE
from osteoporotic
hip fracture in
first year
40%
unable
to walk
independently after
hip fracture
Hospital
admission
More days in
hospital than
other diseases
Costs $17
Billion
in the U.S.
alone
She had a simple fall and is now
in hospital with a broken hip…״
Our Vision
To empower every patient with point-of-care access to accurate and low-cost osteoporosis diagnosis and treatment- monitoring to improve quality of life and prevent death.
Our Solution
First-of-its-kind
360° solution for
bone health care
Today, 80% of individuals at risk from Osteoporosis are not identified or treated. Additionally, over 50% of patients identified and prescribed with a treatment, drop out in less than a year faced with no frequent monitoring solution available. The current DXA gold standard systems have low accessibility, are costly to operate and are not accurate enough for frequent monitoring.
Our new 360° bone health solution will change this status quo by enabling quick, frequent and affordable Bone Mineral Density (BMD) measurements easily via the wrist or pelvis in a physician’s office or at home.
Our first product designed for primary care physicians will enable rapid diagnosis and frequent monitoring in-office. Using our medical device and monitoring solution, physicians will be empowered to identify at-risk patients sooner and optimize treatment effectiveness in months instead of years.
Our technology will be further developed to provide, for the first-time, a homecare solution. As a silent disease with low adherence, using our wearable tracking device and mobile app, patients will now be able to “see” the disease anywhere, anytime, improving treatment compliance and effectiveness.
Faced with the same diagnostic and monitoring methods used for years, our game-changing technology will help transform quality of life for osteoporotic patients throughout the world.
“…most people in America get their care from primary care doctors. We’ve got to get the primary care doctors aboard. Until we do, there is not going to be a lower risk of fractures.”
Dr. Ethel Siris, Madeline C. Stabile Professor of Medicine and Director at Toni Stabile Osteoporosis Center, Columbia University Medical Center.
Reference: “Bone Densitometry Market on the Mend” May 2011, DOTmed Business News
Our Technology
First-of-its-kind
360° solution for
bone health care
By inventing an innovative, validated approach to assess Bone Mineral Density, we can bring huge user and patient benefits that far surpass existing solutions.
With a successful proof of concept and two clinical trials with over 600 patients in established healthcare clinics underway, contact us to support our progress.
SAFE
No radiation risks
AFFORDABLE
For clinics and patients
PORTABLE
For small clinics and home monitoring
CONVENIENT
No operational technician
WELL-SUITED
Designed for
long-term
monitoring
EASY-TO-USE
First wrist measurement outside the clinic
JOIN US TO TRANSFORM BONE HEALTH CARE
Our Leadership
Ze’ev Weinfeld, Ph.D. – CEO
Dr. Weinfeld is an accomplished medical veteran, formerly the CEO of MEDX Xelerator LP and the Founder & CEO of both miCure Therapeutics Ltd. and Ramot at Tel Aviv University Ltd. He has also held senior executive positions as Director at Biosense-Webster (Johnson&Johnson) and Manager at Elscint’s Nuclear Medicine (now GE). He has successfully overseen more than 200 licensing/collaboration deals for over 20 life-science start-ups worth more than $100M.
Prof. Shimon Abboud (Arad) – CTO
Prof. Abboud is a world expert in biomedical signal processing and Electrical Impedance Tomography, and is currently a Professor at Tel Aviv University, where he was formerly Head of the Biomedical Engineering Department. As a biomedical veteran, he has founded two startups and served for over 25 years as Chief Scientist for leading Israeli healthcare companies, Cardiologic Innovations, Medic4All, Card Guard Scientific Survival. He has also published over 100 scientific papers in leading peer-reviewed journals and holds many patents.
Ophir Shahaf, Esq. – Director
VP BD for eHealth Ventures, THE Digital Health Incubator. Ex-CEO of Hadasit Bio Holdings Ltd, a public company (TASE:HDST). Member of the founding team of Clal Biotechnology Industries (CBI), VP BD for Protalix Biopharmaceuticals.
Ethel S. Siris, MD – Unpaid advisor
Dr. Siris is a worldwide recognized authority in Osteoporosis. She is currently the Madeline C. Stabile Professor of Medicine and Director at Toni Stabile Osteoporosis Center, Columbia University Medical Center. She also serves on the Board of Trustees of the National Osteoporosis Foundation in the US and was previously on the Board of the International Osteoporosis Foundation. She is the former past president of the National Osteoporosis Foundation and has served as the Director of NORA, the National Osteoporosis Risk Assessment study.
eHealth Ventures
eHealth Ventures is the leading digital health incubator in Israel. The venture is made up of a consortium of world-class medical organizations including Amgen, Cleveland Clinic and Maccabi Healthcare Services, as well as industry leaders and seasoned investors.
News and events
OsteoSee shares new 360° bone health solution for Osteoporosis at the 1st Congress on Women’s Health Innovations and Inventions (WHII), Israel.
June 24, 2019
June 24, 2019
As a huge unmet women’s health disorder, OsteoSee CEO, Ze’ev Weinfeld, presented the company’s game-changing Osteoporosis solution, enabling rapid diagnosis and frequent monitoring for patients in-office or at home at WHII 2019.
OsteoSee shares new 360° bone health solution for Osteoporosis at the 1st Congress on Women’s Health Innovations and Inventions (WHII), Israel.
June 24, 2019
June 24, 2019
As a huge unmet women’s health disorder, OsteoSee CEO, Ze’ev Weinfeld, presented the company’s game-changing Osteoporosis solution, enabling rapid diagnosis and frequent monitoring for patients in-office or at home at WHII 2019.
OsteoSee is developing the world’s first 360° solution to accurately manage bone health care, anytime, anywhere.
Follow us
OsteoSee is developing the world’s first 360° solution to accurately manage bone health care, anytime, anywhere.